- cafead Jun 13, 2022 at 09:52: PM
via Upon its January approval by the FDA, Roche’s Vabysmo registered an impressive trio of firsts.
It is the first injectable drug in the United States approved simultaneously to treat both wet-age macular degeneration (AMD) and diabetic macular edema (DME). It’s the first bispecific antibody for the eye. And—most importantly—it is the first injectable that can work for up to four months.
article source
It is the first injectable drug in the United States approved simultaneously to treat both wet-age macular degeneration (AMD) and diabetic macular edema (DME). It’s the first bispecific antibody for the eye. And—most importantly—it is the first injectable that can work for up to four months.
article source